Log In
Print
BCIQ
Print
Print this Print this
 

TNT009

  Manage Alerts
Collapse Summary General Information
Company True North Therapeutics Inc.
DescriptionHumanized mAb against complement component 1 s subcomponent (C1S)
Molecular Target Complement component 1 s subcomponent (C1S)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today